As of 2025-05-21, the Fair Value of Amicus Therapeutics Inc (FOLD) is -2.38 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 6.59 USD, the upside of Amicus Therapeutics Inc is -136.19%.
With the market price of 6.59 USD and our fair value calculation, Amicus Therapeutics Inc (FOLD) is not a good investment. Investing in FOLD stocks now will result in a potential loss of 136.19%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -276.90 | -250.50 | -236.60 | -151.58 | -56.11 | -194.34 |
| YoY growth | 22.31% | 9.53% | 5.55% | 35.93% | 62.99% | 27.26% |
| Market Cap (mil) | 2,029.19 |
| P/E | |
| Forward P/E |
| EPS | -0.10 |
| Avg earnings growth rate | 27.26% |
| TTM earnings | -29.37 |